原电池市场规模、份额、成长分析，按类型、原产地、应用、最终用途、地区 - 产业预测，2024-2031 年

2022年全球原电池市场规模估值为12.3亿美元，从2023年的13.6亿美元成长到2031年的30亿美元，预计将以10.4%的复合年增长率成长。

在细胞研究需求不断增长和慢性病患病率上升的推动下，全球原代细胞市场正在显着增长。随着研究人员深入研究疾病状态的遗传和分子基础，对原代细胞的需求迅速增加，从而能够开发出适合个别患者情况的标靶治疗。这些个人化方法正在增强原代细胞在疾病建模和药物筛检中的应用，进一步加速市场扩张。癌症、心血管疾病和神经系统疾病等慢性疾病的流行增加了对这些细胞的需求，这对于研究疾病机制和测试创新疗法至关重要。原代细胞具有忠实再现组织复杂生理环境的能力，对于理解疾病病理学和设计有效的干预措施至关重要。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 监管环境
• 案例研究

原电池市场规模：按类型和复合年增长率（2024-2031）

• 市场概况
• 造血细胞
  • 週边血单一核细胞（PBMC）
  • 骨髓细胞
  • 脐带血细胞
• 皮肤细胞
  • 角质形成细胞
  • 黑色素细胞
  • 纤维母细胞
• 胃肠细胞
  • 结肠上皮细胞
  • 胃上皮细胞
• 肝细胞
  • 肝细胞
  • 枯否细胞
• 肺细胞
  • 肺泡上皮细胞
  • 支气管上皮细胞
• 肾臟细胞
  • 肾臟上皮细胞
  • 肾近曲小管细胞
• 其他细胞
  • 心肌细胞
  • 内皮细胞
  • 神经元

原电池市场规模：依来源及复合年增长率（2024-2031）

• 市场概况
• 人类起源
• 动物起源

原电池市场规模：按应用和复合年增长率（2024-2031）

• 市场概况
• 调查申请
  • 药物发现与开发
  • 癌症研究
  • 免疫学研究
  • 干细胞研究
• 治疗应用
  • 细胞疗法
  • 再生医学

原电池市场规模：依最终用途及复合年增长率（2024-2031）

• 市场概况
• 学术/研究机构
• 製药和生物技术公司
• 医院和诊断实验室
• 细胞库和组织库

原电池市场规模：按地区及复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Thermo Fisher Scientific Inc.
• Lonza Group AG
• Merck KGaA
• PromoCell GmbH
• Cell Biologics Inc.
• ZenBio Inc.
• STEMCELL Technologies Inc.
• AllCells LLC
• American Type Culture Collection（ATCC）
• Axol Bioscience Ltd.
• Creative Bioarray
• ScienCell Research Laboratories Inc.
• BioIVT
• Corning Incorporated
• Bio-Techne Corporation
• Charles River Laboratories International Inc.
• Cureline Inc.
• Cell Applications Inc.
• iXCells Biotechnologies
• Neuromics

结论和建议

Global Primary Cells Market size was valued at USD 1.23 billion in 2022 and is poised to grow from USD 1.36 billion in 2023 to USD 3.0 billion by 2031, growing at a CAGR of 10.4% during the forecast period (2024-2031).

The global primary cells market is witnessing significant growth propelled by heightened demand for cell-based research and the growing incidence of chronic diseases. As researchers delve deeper into the genetic and molecular underpinnings of conditions, the need for primary cells has surged, allowing for the development of targeted therapies suited to individual patient profiles. This personalized approach has intensified the use of primary cells in disease modeling and drug screening, further stimulating market expansion. The prevalence of chronic diseases, including cancer, cardiovascular, and neurological disorders, has amplified the requirement for these cells, essential for studying disease mechanisms and testing innovative therapeutics. Their capacity to closely replicate the complex physiological environments of tissues makes primary cells critical for comprehending disease pathology and crafting effective interventions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Primary Cells market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Primary Cells Market Segmental Analysis

Global Primary Cells Market is segmented by type, origin, application, end use and region. Based on type, the market is segmented into hematopoietic cells, skin cells, gastrointestinal cells, liver cells, lung cells, renal cells and other cells. Based on origin, the market is segmented into human primary cells and animal primary cells. Based on application, the market is segmented into research applications and therapeutic applications. Based on end use, the market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories and cell banks and tissue banks. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Primary Cells Market

The Global Primary Cells market is experiencing robust growth, primarily fueled by recent advancements in Tissue Engineering and Regenerative Medicine. These innovations have elevated the importance of primary cells in creating engineered tissues and organs intended for transplantation. As the medical community increasingly prioritizes regenerative medicine for its potential to address various health issues, the demand for primary cells has surged. This heightened emphasis on tissue engineering not only enhances the capabilities of medical treatments but also significantly contributes to the overall expansion of the primary cells market, reflecting a promising outlook for future developments in healthcare.

Restraints in the Global Primary Cells Market

The global primary cells market is hindered by the inherent limitation of a short shelf life when compared to immortalized cell lines. As primary cells age, they tend to undergo senescence and may gradually lose their unique characteristics, ultimately resulting in diminished functionality. This reduced lifespan creates significant challenges for storage, transportation, and utilization in extended experimental protocols, which can adversely affect their overall market potential. Consequently, researchers and manufacturers must contend with these limitations, impacting the broader adoption and use of primary cells in various applications and hindering growth within the market.

Market Trends of the Global Primary Cells Market

The Global Primary Cells market is experiencing significant growth driven by the rising demand for personalised medicine. This innovative approach emphasizes tailoring medical treatments to individual patients by leveraging their unique genetic profiles and disease characteristics. Primary cells offer a more authentic representation of human biology, making them essential for researchers and pharmaceutical companies focused on developing targeted therapies and conducting preclinical studies. Their ability to facilitate patient-specific response evaluations enhances drug efficacy and safety assessments, thereby accelerating the adoption of primary cells in drug discovery and development. This trend positions the Global Primary Cells market as a vital component of advancing personalized healthcare solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Primary Cells Market Size by By Type & CAGR (2024-2031)

• Market Overview
• Hematopoietic Cells
  • Peripheral Blood Mononuclear Cells (Pbmcs)
  • Bone Marrow Cells
  • Cord Blood Cells
• Skin Cells
  • Keratinocytes
  • Melanocytes
  • Fibroblasts
• Gastrointestinal Cells
  • Colonic Epithelial Cells
  • Gastric Epithelial Cells
• Liver Cells
  • Hepatocytes
  • Kupffer Cells
• Lung Cells
  • Alveolar Epithelial Cells
  • Bronchial Epithelial Cells
• Renal Cells
  • Renal Epithelial Cells
  • Renal Proximal Tubule Cells
• Other Cells
  • Cardiomyocytes
  • Endothelial Cells
  • Neurons

Global Primary Cells Market Size by Origin & CAGR (2024-2031)

• Market Overview
• Human Primary Cells
• Animal Primary Cells

Global Primary Cells Market Size by Application & CAGR (2024-2031)

• Market Overview
• Research Applications
  • Drug Discovery and Development
  • Cancer Research
  • Immunology Research
  • Stem Cell Research
• Therapeutic Applications
  • Cell Therapy
  • Regenerative Medicine

Global Primary Cells Market Size by End Use & CAGR (2024-2031)

• Market Overview
• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Hospitals and Diagnostic Laboratories
• Cell Banks and Tissue Banks

Global Primary Cells Market Size & CAGR (2024-2031)

• North America (Type, Origin, Application, End Use)
  • USA
  • Canada
• Europe (Type, Origin, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Origin, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Origin, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Origin, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PromoCell GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Biologics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZenBio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AllCells LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• American Type Culture Collection (ATCC)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axol Bioscience Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Bioarray
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScienCell Research Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioIVT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cureline Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Applications Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• iXCells Biotechnologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuromics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations